A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis | MicrobiomeTrials← Back to trialsNCT07223697
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-01-08Est. Completion: 2033-03-01
Enrollment target: 120 participants Locations- UCLA Division of Dermatology, Los Angeles, California, United States
- Dermatology Research Associate, Los Angeles, California, United States
- Olympian Clinical Research, Tampa, Florida, United States
- Hamilton Research, LLC, Alpharetta, Georgia, United States
- Revival Research Institute, LLC, Troy, Michigan, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- Best Skin Research LLC, Camp Hill, Pennsylvania, United States
- Centro de Estudos em Terapias Inovadoras ? CETI, Curitiba, Paraná, Brazil
- Irmandade Da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
- Hospital de Clnicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
- UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu, Botucatu, São Paulo, Brazil
- Centro de Pesquisa São Lucas, Campinas, São Paulo, Brazil
- HMCG - Hospital e Maternidade Dr. Christovo da Gama, Santo Andr, São Paulo, Brazil
- Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS, Sao Jose Rio Preto, São Paulo, Brazil
Other microbiome trials you might be interested in
Atopic Dermatitis (AD)
The goal of this clinical trial is to learn if drug LT-002-158 works to treat moderate-to-severe atopic dermatitis in ad…
Hangzhou, ChinaEst. completion Jan 2028
Atopic DermatitisEczema
The main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months t…
Birmingham, United StatesCompleted Dec 2027
Instituto Brasil de Pesquisa Clínica-IBPCLIN S/A, Rio de Janeiro, BrazilDermEffects, London, Ontario, CanadaLynderm Research Inc, Markham, Ontario, CanadaDermEdge Research, Mississauga, Ontario, CanadaRyan Clinical Research Inc, Newmarket, Ontario, CanadaFachklinik Bad Bentheim, Bad Bentheim, Lower Saxony, GermanyDermatologikum Hamburg Gemeinschaftspraxis GbR, Hamburg, GermanyFondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Lazio, ItalyAzienda Ospedaliero Universitaria delle Marche, Ancona, The Marches, ItalyCentrum Medyczne Pratia Katowice I, Katowice, Silesian Voivodeship, PolandCentrum Medyczne Pratia Gdynia, Gdynia, PolandSpecjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy Marek Brzewski, Pawel Brzewski s.c., Krakow, PolandCentrum Nowoczesnych Terapii "Dobry Lekarz", Krakow, PolandUniwersytecki Szpital Kliniczny im.Fryderyka Chopina w Rzeszowie, Rzeszów, PolandKlinika Ambroziak Dermatologia, Warsaw, PolandClinica Universidad de Navarra, Pamplona, Navarre, SpainHospital Universitario Reina Sofia, Córdoba, SpainEczemaDermatitisSkin Diseases, GeneticDermatitis, AtopicSkin Diseases
Background:
\- Atopic dermatitis, or eczema, is a chronic skin disorder. Patients sometimes have infections with S. aur…
Bethesda, United StatesEst. completion Jan 1, 2027